Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, how many women have reported problems to the Medicines and Healthcare Products Regulatory Agency about the Essure implant in the last five years.

Following the suspension of the CE certificate for Essure devices, the manufacturer has agreed to voluntarily quarantine Essure stock in the United Kingdom. Patient safety is our highest priority and we encourage the reporting of any adverse incidents to the Medicines and Healthcare products Regulatory Agency (MHRA), regardless of how long ago the implant was inserted. The MHRA are bound by UK and European Union legislation that preclude us from releasing the information that has been requested. However, there is currently no evidence to suggest any increased risk to patient safety. Any women with questions should speak to their general practitioner or healthcare professional.